All Updates

For the second year in a row, legislation to increase access to biomarker testing has failed to pass in the final days of legislative activity.

Federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House. Sponsored by Reps. Raul Ruiz (D-Calif.) and Larry Bucshon (R-Ind.), the Clinical Trial Modernization Act is bipartisan legislation that would increase access to clinical trials by helping remove cost and geographic barriers to patient participation.

Federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House. Sponsored by Reps. Raul Ruiz (D-Calif.) and Larry Bucshon (R-Ind.), the Clinical Trial Modernization Act is bipartisan legislation that would increase access to clinical trials by helping remove cost and geographic barriers to patient participation.

Members of the newly formed Arizona Cancer Action Caucus held their inaugural meeting Wednesday afternoon at the state capitol to discuss ways to combat the disease in the state. The American Cancer Society Cancer Action Network (ACS CAN) helped form the caucus, which consists of a bipartisan group of seven state lawmakers. All members have been touched by cancer, including some who are survivors.

By ensuring more Mainers have biomarker testing covered by their insurance plans, we can increase access to personalized medicine and realize better outcomes for cancer patients as well other disease groups. It's time for Gov. Mills to act to make this a reality.

After years of grassroots organizing and campaign work in the Western states, Audrey Miller García has been named the American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director for her home state of Washington. In this role she will lead ACS CAN’s efforts to advance legislation and public policies to reduce the cancer burden in the Evergreen State.

Nearly half (49%) of cancer patients and survivors report being burdened by medical debt alongside some (13%) who report expecting to incur medical debt as part of their treatment plan, according to a new Survivor Views survey by the American Cancer Society Cancer Action Network (ACS CAN).

Nearly half (49%) of cancer patients and survivors report being burdened by medical debt alongside some (13%) who report expecting to incur medical debt as part of their treatment plan, according to a new Survivor Views survey by the American Cancer Society Cancer Action Network (ACS CAN).

The American Cancer Society Cancer Action Network (ACS CAN) applauds the Colorado General Assembly for taking a great first step to increasing access to biomarker testing by passing SB24-124. The bill was met with strong bi-partisan support in both the House and Senate. With the legislative process now complete, the bill now awaits the signature of Governor Jared Polis. If enacted, the policy would help connect more patients diagnosed with cancer or other diseases with the right treatment at the right time through biomarker testing.